Ayse Ulusoy Selected Research

Mitochondrial Diseases (Mitochondrial Disease)

1/2018

Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ayse Ulusoy Research Topics

Disease

18	Parkinson Disease (Parkinson's Disease) 10/2023 - 08/2008
9	Synucleinopathies 11/2021 - 04/2013
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 08/2008
4	Disease Progression 07/2018 - 01/2011
2	Inflammation (Inflammations) 12/2022 - 07/2012
1	Iron Overload 01/2021
1	Cognitive Dysfunction 01/2020
1	Pathologic Processes 07/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Neuroinflammatory Diseases 07/2012
1	Drug-Induced Dyskinesia (Dyskinesia, Drug Induced) 07/2010
1	Dyskinesias (Dyskinesia) 07/2010

Drug/Important Bio-Agent (IBA)

15	SynucleinsIBA 10/2023 - 01/2010
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2012
3	alpha-SynucleinIBA 01/2022 - 08/2010
3	Dopamine (Intropin)FDA LinkGeneric 09/2012 - 08/2008
2	Neuroprotective AgentsIBA 01/2021 - 08/2011
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2022
1	LipidsIBA 11/2021
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2021
1	IronIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Oxidants (Oxidizing Agents)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 02/2012
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 08/2011
1	NeurotoxinsIBA 08/2011
1	Therapeutic UsesIBA 08/2011
1	Nerve Growth Factors (Neurotrophins)IBA 01/2011
1	PolymersIBA 08/2010
1	Apomorphine FDA Link 07/2010
1	Levodopa (L Dopa)FDA LinkGeneric 07/2010

Therapy/Procedure

1	Oral Administration 12/2022
1	Precision Medicine 01/2022
1	Therapeutics 01/2011